Cushing syndrome and Cushing disease: Clinical sciences

Last updated: July 08, 2025

Cushing syndrome and Cushing disease: Clinical sciences

580

580

Well-patient care (adult): Clinical sciences
Approach to common skin rashes: Clinical sciences
Approach to skin and soft tissue infections: Clinical sciences
Approach to skin and soft tissue lesions: Clinical sciences
Approach to skin and soft tissue injury: Clinical sciences
Benign skin lesions: Clinical sciences
Cellulitis and erysipelas: Clinical sciences
Folliculitis, furuncles, and carbuncles: Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Approach to joint pain and swelling: Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Approach to back pain: Clinical sciences
Approach to ankle pain: Clinical sciences
Approach to hip pain: Clinical sciences
Approach to knee pain: Clinical sciences
Approach to shoulder pain: Clinical sciences
Chronic low back pain: Clinical sciences
Gout: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Psoriatic arthritis: Clinical sciences
Septic arthritis: Clinical sciences
Reactive arthritis: Clinical sciences
Osteoporosis: Clinical sciences
Calcium pyrophosphate deposition disease (pseudogout): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Thyroid nodules: Clinical sciences
Adrenal insufficiency: Clinical sciences
Cushing syndrome and Cushing disease: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Hyperparathyroidism: Clinical sciences
Eyelid disorders: Clinical sciences
Upper respiratory tract infections: Clinical sciences
Approach to a cough (acute): Clinical sciences
Approach to a cough (subacute and chronic): Clinical sciences
Chest X-ray interpretation: Clinical sciences
Chronic obstructive pulmonary disease: Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Pulmonary embolism: Clinical sciences
Sleep apnea: Clinical sciences
Influenza: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Asthma: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Approach to hypertension: Clinical sciences
Essential hypertension: Clinical sciences
Dyslipidemia: Clinical sciences
Congestive heart failure: Clinical sciences
Approach to anemia (destruction and sequestration): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Iron deficiency anemia: Clinical sciences
Vitamin B12 deficiency: Clinical sciences
Immunizations (adult): Clinical sciences
Approach to primary immunodeficiencies: Clinical sciences
Human immunodeficiency virus (HIV) infection: Clinical sciences
Multiple myeloma: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Approach to constipation: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Diverticulitis: Clinical sciences
Celiac disease: Clinical sciences
Appendicitis: Clinical sciences
Chronic pancreatitis: Clinical sciences
Hemorrhoids: Clinical sciences
Hepatitis B: Clinical sciences
Infectious gastroenteritis: Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Irritable bowel syndrome: Clinical sciences
Peptic ulcer disease: Clinical sciences
Cervical cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Breast cancer screening: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Approach to dysuria: Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Nephrolithiasis: Clinical sciences
Chronic kidney disease: Clinical sciences
Prerenal acute kidney injury: Clinical sciences
Approach to anxiety disorders: Clinical sciences
Approach to mood disorders: Clinical sciences
Substance use disorder: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to dizziness and vertigo: Clinical sciences
Approach to chest pain: Clinical sciences
Colorectal cancer screening: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Cushing syndrome refers to a combination of clinical features and symptoms that arise as a result of long-term exposure to high glucocorticoid levels in the blood. Based on the underlying cause, Cushing syndrome can be iatrogenic, which occurs from exogenous administration of glucocorticoids; ACTH-independent, which is specific to adrenal cortisol hypersecretion; and ACTH-dependent, which can be due to either ectopic ACTH secretion by non-pituitary tumors or excessive pituitary ACTH secretion.

Moreover, Cushing syndrome caused by excessive secretion of ACTH by pituitary adenoma is called Cushing disease!

Now, if your patient presents with a chief concern suggesting Cushing syndrome, the first step is to obtain a focused history and physical examination as well as labs, including a basic metabolic panel or BMP.

High glucocorticoid levels in the blood affect almost every system in the body, so your patient will have various clinical manifestations. For example, history will often reveal central nervous system symptoms, such as irritability and depressed mood; as well as metabolic conditions, like glucose intolerance or diabetes mellitus. Next, high glucocorticoid levels can suppress gonadotropin secretion, so your patients might report symptoms involving the reproductive system, like decreased libido and amenorrhea.

The physical exam reveals the glucocorticoid effects on fat redistribution and findings like central obesity, moon facies or round face, and “buffalo hump”, which refers to fat accumulation on the back of the neck. Additionally, you might notice skin changes, such as thin skin, acne, hirsutism, and purple and broad abdominal striae!

Next, let’s take a look at cardiovascular findings! Normally, the kidneys inactivate cortisol by converting it into cortisone, which cannot bind mineralocorticoid receptors and exert cardiovascular effects.

But, in Cushing syndrome, there’s too much cortisol, so the kidneys are unable to inactivate everything from the blood. As a result, cortisol remains active and begins binding mineralocorticoid receptors in the kidneys, subsequently causing sodium reuptake and increasing potassium excretion! Ultimately, this leads to findings such as elevated blood pressure and peripheral edema.

Next, let’s take a look at muscles! Since glucocorticoids stimulate protein degradation, you might notice muscular atrophy, especially of gluteal and upper leg muscles!

Finally, as far as labs go, keep in mind that your patient is losing potassium through the kidneys, so you will often notice hypokalemia. Additionally, your patient might present with hyperglycemia due to glucose intolerance or uncontrolled diabetes mellitus.

Now, with these findings, you should suspect Cushing syndrome, so your next step is to determine the underlying cause!

First, check if there’s a long-term use of exogenous glucocorticoids. Exogenous glucocorticoids come in many forms, so be sure to specifically ask about all delivery methods of glucocorticoids, including oral, injection, inhaler, or topical, which are typically used to treat various inflammatory conditions!

Now, if your patient has been prescribed exogenous glucocorticoids to treat a specific inflammatory condition, you can clinically diagnose Iatrogenic Cushing syndrome!

In this case, the management consists of lowering the dosage, or if possible, gradually tapering off the medication.

On the flip side, if there is no exogenous glucocorticoid use, you need to assess if your patient’s blood cortisol levels are truly elevated before going any further.

To do this, you can obtain either a late-night salivary cortisol, a 24-hour urinary free cortisol level, or a low-dose overnight dexamethasone suppression test. Now, if cortisol levels are below, or within the reference range, then your patient does not have Cushing syndrome, so you should consider alternative diagnoses.

However, if cortisol levels exceed the reference range, you can confirm the diagnosis of Cushing syndrome. Your next step is to assess the underlying cause by obtaining a plasma adrenocorticotropic hormone or ACTH level test.

If the plasma ACTH level is below the reference range, diagnose ACTH-independent Cushing syndrome, which typically occurs due to excessive cortisol secretion by the adrenal glands.

Next, obtain an adrenal gland imaging, like CT or MRI. Imaging will typically reveal either an adrenal tumor or adrenal gland hyperplasia. With these findings, diagnose adrenal cortisol hypersecretion as the cause of Cushing syndrome!

Now, here’s a clinical pearl to keep in mind! Important conditions associated with adrenal cortisol hypersecretion include adrenocortical adenoma and adrenocortical carcinoma, as well as macronodular adrenal hyperplasia.

Once you determine the cause of ACTH-independent Cushing syndrome, consult your surgery team for tumor resection or bilateral adrenalectomy in case of adrenal hyperplasia. Following adrenalectomy, your patient will require a life-long glucocorticoid and mineralocorticoid replacement. Other treatment options include medical therapy with adrenal steroidogenesis inhibitors like mitotane, which can help manage symptoms of excess cortisol.

Sources

  1. "Consensus on diagnosis and management of Cushing's disease: a guideline update" Lancet Diabetes Endocrinol (2021)
  2. "The Pathophysiology and Treatment of Hypertension in Patients with Cushing's Syndrome" Front Endocrinol (Lausanne) (2019)
  3. "Harrison's Principles of Internal Medicine, 21e." McGraw Hill (2022)
  4. "Adrenal Cortex" Goldman Cecil Medicine, 26th ed. (2020)
  5. "Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline" J Clin Endocrinol Metab (2015)
  6. "The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline" J Clin Endocrinol Metab (2008)
  7. "Anterior Pituitary" Goldman Cecil Medicine, 26th ed. (2020)